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Abstract 
Background: This first mixed-methods UK trial examined the feasibility and acceptability of a future definitive ran-
domised controlled trial (RCT) to evaluate whether Family Focussed Treatment for Adolescents with Bipolar Disorder 
(FFT-A) UK version can improve family functioning and well-being as part of the management of Paediatric Bipolar 
Disorder (PBD).
Method: The trial used a randomised, parallel group, non-blinded design where participants received FFT-A UK (16 
sessions over 6 months) immediately or after 12 months (delayed arm). Measures of family functioning, well-being 
and quality of life of the young person and the main carer (most commonly a parent) were completed at baseline, 
6 and 12-months in both arms. Primary outcome measures included rates of eligibility, consent and retention along 
with estimates of variability in the measures and assessment of the intervention delivery. Qualitative interviews 
allowed assessment of participants’ views about FFT-A and the trial processes.
Results: Twenty-seven of 36 young persons with PBD and their families consented; of these, 14 families were ran-
domised to the immediate and 13 to the delayed arm. Two families from the immediate arm withdrew consent and 
discontinued participation. Quantitative measures were completed by 22 families (88%) at 6-months and 21 families 
(84%) at 12-months. Qualitative interviews were conducted with 30 participants (9 young people, 15 parents and 6 
other family members). Nine families attended 3 post-trial focus groups.
Conclusion: It was feasible to recruit and retain to this trial. The results highlighted that trial design and measures 
were acceptable to participants. A benefit in family relationships was reported by participants which they attributed 
to the intervention in qualitative interviews. Families recommended that future modifications include definitive trial(s) 
recruiting participants in the age range 15–25 years as it felt this was the age range with maximum need.
Trial registration ISRCTN, ISRCTN59769322. Registered 20 January 2014, http://www.isrct n.com/ISRCT N5976 9322
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Background
Paediatric Bipolar Disorder (PBD: defined as diagnosis 
prior to 18  years of age) is often associated with more 
severe disease course, poorer functioning and impaired 
quality of life compared to the later onset of the disorder 
(Perlis et al. 2004). PBD is infrequently diagnosed in the 
UK (Chan et al. 2011; Stringaris et al. 2010; Sharma et al. 
2016) although UK guidelines state that the peak age of 
onset is 15 to 19 years (NICE 2014).
Bipolar disorder impacts not only on the person 
affected but also their family. Our group (Barron et  al. 
2014) has reported significantly higher scores for 
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intrafamilial conflict in families with Bipolar Disorder 
in NE England compared with healthy control families 
using the Family Environment Scale (Moos and Moos 
1994). Belardinelli et  al. (2008) have similarly reported 
significantly lower levels of family cohesion, expressive-
ness, active-recreational orientation, intellectual-cultural 
orientation and higher levels of conflict when comparing 
family environment in families with PBD to families who 
had no history of PBD. Further, in a US study of families 
with PBD, more minor conflicts occurred between fam-
ily members than in either control group or families with 
a child with depression (Robertson et al. 2001). There is 
also evidence showing that parental attitudes, and in par-
ticular high levels of criticism or emotional over-involve-
ment regarding the child—is a prospective risk factor for 
mood recurrences (Miklowitz et al. 2009). Furthermore, 
stress and the burden of caring for an ill relative are likely 
to increase negativity in the family environment (Casarez 
et  al. 2019), and could in turn become a risk factor for 
subsequent episodes of bipolar disorder (Miklowitz and 
Chang 2008). Studies assessing family-based interven-
tions which could reduce burden on the whole family as 
part of the long-term management of PBD are critically 
needed.
Psychotherapeutic studies targeting families with PBD 
in USA include child and family-focused cognitive-
behavioural therapy (CFF-CBT) (Pavuluri et  al. 2004; 
West et  al. 2014) and Family-Focused Treatment for 
Adolescents (FFT-A) (Miklowitz et al. 2003). FFT-A was 
reported to be associated with an improvement in mood 
symptoms over 2  years (Miklowitz et  al. 2008): PBD 
who received FFT-A along with medication had shorter 
depressive episodes and milder depressive symptoms 
compared to enhanced care which consisted of 3 fam-
ily sessions focused on relapse prevention along with 
medication.
Given the low rates of diagnosis of PBD in the UK 
compared to USA, the cultural differences between USA 
and UK health care systems which prevent the direct 
extrapolation of published clinical effectiveness findings 
from USA, and in the absence of UK cost effectiveness 
data, the authors recognised the importance of under-
taking a UK pilot feasibility and acceptability trial prior 
to embarking on a definitive randomised controlled trial 
(RCT) to evaluate the efficacy of Family Focussed Treat-
ment for Adolescents with Bipolar Disorder (FFT-A) UK 
version in the UK NHS context.
Aims of the trial
The aim of this trial was to employ a randomised, par-
allel group, non-blinded design allowing participants to 
either receive FFT-A UK (16 sessions over 6  months) 
immediately or after 12 months (delayed arm) to examine 
the feasibility and acceptability of a future definitive RCT. 
The specific objectives of this feasibility trial (Neely et al. 
2015) were to investigate:
1. Whether it is feasible to deliver the FFT-A UK to 
young people with PBD (11–17 years) and their fami-
lies?
2. What are the likely eligibility, consent and retention 
rates as well as the acceptability of being randomised 
to a delayed treatment arm?
3. What are young person and their family’s views 
about receiving the FFT-A intervention, taking part 
in an RCT, and completing the trial assessments and 
outcome measures.
4. What is the variability in the validated parent report 
and self-report quantitative questionnaires?
Materials and methods
Trial design
The feasibility and acceptability trial used a mixed 
quantitative and qualitative methods design with two 
components:
1. A single-centre, open randomised controlled trial of 
FFT-A UK in the management of PBD compared to 
treatment as usual. The primary feasibility outcomes 
included rates of recruitment, randomisation, reten-
tion and data completion and the variability in scores 
on the proposed validated questionnaires.
2. Qualitative interviews of families eligible for the 
intervention to investigate the acceptability of both 
the FFT-A UK intervention and the procedures and 
measures proposed for use in a definitive RCT.
Ethical and research governance approval
The trial received a favourable ethical opinion by Sun-
derland NHS Research Ethics Committee (13/NE/0117) 
and was registered with Current Controlled Trials 
ISRCTN59769322. Research sponsorship was provided 
by Northumberland Tyne and Wear NHS Foundation 
Trust.
Participants
Inclusion criteria
Families were eligible for recruitment into the trial if a 
young person in the family was between 11 and 17 years 
old with a confirmed diagnosis of PBD (in remission) 
as assessed by Washington University at St. Louis Kid-
die Schedule for Affective Disorders and Schizophrenia 
(WASH-U-KSADS) (Geller et  al. 1996). Young people 
and their family members needed to be prepared to be 
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randomised, be fluent in the English language and have 
intellectual ability in the average range (ascertained by 
the referring consultant in child and adolescent psychia-
try on a clinical basis), in order to complete the measures 
and take part in the intervention.
Eligibility assessment
Washington University in St. Louis Kiddie Schedule 
for Affective Disorders and Schizophrenia (WASH-U-
KSADS) (Geller et al. 1996) is a semi-structured, clinician 
administered assessment of psychopathology in children 
and adolescents under the age of 18  years. The subject 
and informant version of this reliable and valid interview 
schedule was completed with the young person and his/
her parent/carer respectively by AS who has received 
training on this measure at Washington University, St 
Louis, USA.
Baseline characterisation
Children’s Global Assessment Scale (CGAS) (Shaffer 
et al. 1983) is a clinical assessment tool that rates the gen-
eral functioning of youths under the age of 18. The child 
or young person is given a score between 1 and 100 that 
relates to one of ten categories ranging from ‘extremely 
impaired’ (1–10) to ‘doing very well’ (91–100).
Demographics
Case Report Form (CRF) is a bespoke measure designed 
to collect demographic and medical information about 
the participants including data on additional diagnoses, 
medications taken, previous manic and depressive epi-
sodes and previous family medical history.
Quantitative measures
The Family Assessment Device (FAD) (Epstein 1983) 
is a self-report caregiver/family member 60 item ques-
tionnaire that evaluates dynamic characteristics of fami-
lies and is typically completed by family members aged 
12 years or older. Each item is rated on a four-point Likert 
scale, ranging from ‘strongly agree’ to ‘strongly disagree’. 
The FAD provides assessment of six domains (problem 
solving, communication, roles, affective responsiveness, 
affective involvement, and behaviour control) together 
with a general functioning domain that can be used as a 
global measure of family functioning (Byles et al. 1988). 
The total scale scores range from 1 to 4, with higher 
scores indicating unhealthy functioning. The question-
naire is reported to have good psychometric properties 
(Miller et al. 2000).
Conflict Behaviour Questionnaire (CBQ) (Prinz et  al. 
1979) is a self-report measure available in two versions 
(adolescent and parent) assessing problems with com-
munication style and interpersonal behaviours within 
adolescent-parent dyads during the past 2  weeks. The 
original adolescent version has been used with both 
young people aged between 11 and 15  years and with 
older adolescents aged 12 to 17 years old (e.g. Prinz et al. 
1979). The two short versions have 44 items, answerable 
in a true/false format and yield four scores: adolescent’s 
appraisal of parent, adolescent’s appraisal of dyad, paren-
tal appraisal of adolescent and parental appraisal of dyad. 
Each scale provides a single score, with higher scores 
indicating less troubled relationships.
Warwick Edinburgh Mental Wellbeing Scale (WEM-
WBS) (Tennant et  al. 2007) is a self-report 14 items 
questionnaire assessing both emotional and functional 
aspects of mental wellbeing during the past 2  weeks in 
those who are 16 years old or older. The items are rated 
on a five-point Likert scale, ranging from ‘none of the 
time’ to ‘all of the time’. The questionnaire provides a sin-
gle score ranging from 14 to 70, with higher scores indi-
cating better wellbeing. The psychometric properties of 
the WEMWBS are robust (Lloyd and Devine 2012).
EQ-5D-L and EQ-5D-Y are standardised measures 
of health status designed for people aged 12  years or 
more and young people (aged from 5 to 18 years of age), 
respectively. Both versions of the measure have five 
dimensions: mobility, self-care, usual activities, pain/
discomfort and anxiety/depression and are scored on a 
three-level descriptive system: no problems, some prob-
lems, and extreme problems. The measures provide also 
an EQ visual analogue scale (EQ VAS) that records the 
respondent’s self-rated health on a vertical, visual ana-
logue scale ranging from ‘Worst imaginable health state’ 
to ‘Best imaginable health state’. The score can range 
between 0 and 100, and higher scores represent better 
imaginable health state.
Qualitative measures
In-depth qualitative interviews were conducted with par-
ticipants (from both arms of the trial) after completion 
of 12-month follow-up. The interviews explored young 
peoples’ and other family members’ perspective about 
their participation in the trial and their experience of the 
FFT-A UK intervention (trial aim 3). Purposive sampling 
was used to achieve maximum variation across the fol-
lowing variables: age of young person, gender, geographic 
location, and family member’s relationship to the young 
person. A semi-structured topic guide was developed to 
explore the acceptability of the trial processes and expe-
rience of the intervention. Interviews were held at the 
family home or a nearby health centre, depending upon 
participant preference. As the FFT-A UK version was 
designed to engage families, interviews were usually con-
ducted with more than one family member present.
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Sample size considerations
Following published recommendations for feasibility 
studies (Lancaster et al. 2004), no formal sample size cal-
culation was performed. The target sample size was 33 
families with an estimated attrition rate of 10% allowing 
for final data analysis on 30 families thereby providing 
sufficient data to assess feasibility and estimate the vari-
ability in the outcome measures.
Procedures
Recruitment
Participants were recruited through local community 
child and adolescent mental health services in North 
East England; the National second opinion Adolescent 
Bipolar Service (based in Newcastle, UK); and through 
an advert placed in the ‘Pendulum’, a UK national bipolar 
support organisation newsletter (Bipolar UK) for young 
people living in North East England which signposted 
young people to contact their local community child and 
adolescent mental health service. All consecutive eligi-
ble participants attending these clinical services were 
approached by their consultants in child and adolescent 
psychiatry to take part in the trial.
Consent
An adult family member (usually a parent) was required 
to give written informed consent for their own partici-
pation and for a young person aged 11–15  years in the 
trial. Young people aged 11–15  years gave their written 
informed assent whilst those aged 16–17 years gave writ-
ten informed consent to participate in the trial. Upon 
completion of the FFT-A UK, either in the immediate or 
delayed arm, subsequent written informed consent and 
assent was taken for the qualitative interviews. Those 
consenting were contacted by a member of the research 
team to discuss a suitable date, time and venue for the 
qualitative interviews.
Randomisation and blinding
Participants were randomised to ‘immediate treatment 
arm’ or ‘delayed treatment arm’ in a 1:1 ratio, using ran-
dom permuted blocks of sizes 2 and 4. The randomisa-
tion allocation schedule was generated by a statistician 
with no other involvement in the trial. Randomisation 
was performed by a trained member of the research 
team, using a secure password-protected Web-based sys-
tem administered by Newcastle Clinical Trials Unit. The 
trial coordinator and trial statistician remained blind to 
allocation group. However, blinding was not feasible for 
the trial participants or Chief Investigator.
Data collection
Participants (young people and parents) completed 
validated questionnaires at baseline, 6- and 12-months 
post baseline. The completion time of the question-
naires at each timepoint was approximately 30  min. 
Young people and parents completed the measures 
which were taken to them by Clinical Studies Officers 
from the Clinical Research Network for North East and 
North Cumbria. This was to minimise contact with trial 
coordinator and trial statistician to prevent unblinding. 
Young people were given a gift voucher (to the value of 
£10) on completion of each batch of questionnaires.
Intervention
Immediate treatment
Once randomised to immediate treatment, young peo-
ple and family members either living with or involved 
(as defined by the young person) in the care of the 
young person, were invited to attend the FFT-A-UK 
intervention in addition to Treatment As Usual (TAU).
The FFT-A-UK consisted of 16 1-h sessions over 
25 weeks at a clinical venue of the families’ choice:
• seven weekly psycho-education sessions focus-
ing on the aetiology, treatment, self-management, 
relapse prevention plan and identifying early pro-
dromal signs of bipolar disorder;
• four fortnightly communication enhancement ses-
sions concentrating on teaching young people and 
their family members communication skills, such 
as offering positive feedback, active listening, mak-
ing positive requests for change in others’ behav-
iour and giving negative feedback;
• four fortnightly problem-solving skill training 
sessions aiming to encourage an open dialogue 
between family members about difficult topics and 
help all involved to develop strategies for solving 
these problems;
• one final overview session completing the interven-
tion.
FFT‑A modification to FFT‑A UK version
With DM’s (the author of the Family Focused Treat-
ment-Adolescent (FFT-A)) agreement the FFT-A 
was adapted for the UK context by AS. Modifications 
included reducing the total number of sessions [from 21 
delivered over 9 months to 16 delivered over 6 months. 
Some cultural modifications such as word changes were 
also made. The revised FFT-A UK version targets the 
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same FFT-A key domains of psychoeducation, commu-
nication enhancement and problem-solving.
Therapy training
All therapists attended a 1-day training workshop on the 
FFT-A UK delivered by DM and AS. Throughout the fea-
sibility trial the therapists received bi-weekly supervision 
from AS, and bi-monthly Skype supervision and written 
feedback from DM.
Fidelity of intervention
All therapy sessions were video-recorded and 25% were 
viewed by DM for purposes of fidelity monitoring, using 
the 11-item Therapist Competence and Adherence Scale 
(Weisman et al. 1998). The item scores range from 1 (very 
poor) to 7 (excellent).
Data analysis
Quantitative outcome measures
Analyses followed a pre-specified Statistical Analysis 
Plan. In accordance with recommendations for the anal-
ysis of feasibility studies (Lancaster et  al. 2004) analy-
ses were descriptive only and statistical comparisons 
between randomised groups were not undertaken.
Eligibility, consent, and retention rates were calculated 
as defined. The validated questionnaires were scored 
according to the scoring algorithms provided (Epstein 
et  al. 1983; NHS 2015). The scale means for the WEM-
WBS and subscale means for the FAD were used to 
impute missing items (Davidson and Mellor 2001; Bei-
erlein et  al. 2017; Bartram et  al. 2011). At baseline and 
by randomised group the distributions of all numeri-
cal demographic and clinical variables were examined 
graphically and summarised by measures of location and 
spread. Baseline categorical variables were tabulated, and 
percentages reported. The questionnaire data were sum-
marised by means and standard deviations at baseline, 
6 months and 12 months for all participants with evalua-
ble data at these time points; the purpose being to inform 
the design of any future definitive trials. Given the size 
of the trial and its feasibility objectives, no interpretation 
has been made of any apparent changes in the question-
naire data over time.
Qualitative interviews
All interviews were audio-recorded and transcribed 
verbatim. Analysis was conducted using anonymised 
transcripts. The semi-structured nature of the inter-
views and a priori themes meant that a largely deductive 
approach was taken to data coding, though the process 
remained flexible enough to encompass emerging issues. 
Codes were applied relevant to experience of trial par-
ticipation and the intervention. The lead qualitative 
researcher (RM) conducted all interviews and coding, 
and initial analysis was refined following discussions 
with the research team (AS, MG, KM, SH) leading to the 
final interpretation. Findings are illustrated by exemplar 
quotes across all interviewees.
Results
Feasibility
Across the recruiting sites, 36 potentially eligible young 
people with PBD were approached by their Consultants 
in Child and Adolescent Psychiatry. All but one agreed 
to consider the trial. Of the 36 potentially eligible fami-
lies, 32 (89%) expressed interest in participating in the 
trial and 27 (75%) consented to take part. An unavoid-
able research funding constraint (17  months into the 
trial) resulted in a delay of 5  months with recruitment. 
This delay meant that 5 young people (3 male, 2 female) 
and their families—although having expressed an inter-
est in participating in the trial –no longer met the inclu-
sion criteria when the trial resumed because the young 
people were over the age of 18  years. Fourteen fami-
lies were randomised to the immediate treatment arm 
of which 2 families withdrew consent after receiving 
between 4 and 5 sessions of the intervention. Retention 
rate, defined as number of participants completing their 
allocated treatment, was 24/27 families (89%). Twelve 
families (range of 2–5 family members) completed the 
treatment in the immediate arm, attending between 12 
and 16 sessions (median = 15.5) over between 3 months 
29 days to 10 months 16 days (median 6 months 5 days). 
At 6  months the measures were completed by 11 fami-
lies in both the immediate and the delayed arms, and at 
12  months by 10 families in the immediate arm and 11 
families in the delayed arm (Fig. 1).
Baseline demographic and clinical characteristics
At baseline the two groups were balanced in terms of 
demographic and clinical characteristics (see Tables  1 
and 2). Questionnaires were completed by 22 (88%) of 
the families at the 6 months and 21 (84%) at 12 months.
Fidelity monitoring of psychotherapy
The average overall adherence/competence rating was 
4.18 (SD = 0.40; range 1–7) indicating a good level of 
adherence on the TCAS scale.
Quantitative measures
The WEMWBS, FAD, CBQ-parent and CBQ-adolescent 
were examined for completion. Data quality was high 
with no missing items for the CBQ-parent and CBQ-ado-
lescent and only a small number of missing items for the 
WEMWBS and the FAD so that an overall score could be 
calculated according to the scoring algorithm (Table 2).
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Health economics
The responses to the EQ-5D-Y appeared to suggest that 
young people experienced relatively few problems with 
mobility and with looking after themselves compared 
with the other questions. A similar pattern was found 
for carers. With respect to the visual analogue score, 
as would be expected there was considerable variation 
between respondent both for the young people and 
carers.
Qualitative findings
Nine young people M:F: 1:8), 15 parents (Fathers: 
Mothers: 12:3) and 6 other family members (n = 3 sib-
lings, n = 2 grandmothers, n = 1 partner) consented to 
be interviewed. Eighteen interviewees were from the 
immediate arm group (6 young people, 8 mothers, 1 
father, 1 sibling, 2 grandmothers) and twelve were from 
the delayed arm (3 young people, 4 mothers, 2 fathers, 
2 siblings, 1 partner). The average number of interview-
ees present in the interviews was two (range 1–5). The 
average duration of the interviews was 1  h and 5  min 
(range 29 min–1 h and 26 min).
Acceptability of intervention and research processes 
and procedures
Participating young people and their family members 
spoke positively about the trial. Typically, a view was 
shared that research was important and necessary to 
identify effective interventions for young people diag-
nosed with PBD. Moreover, the inclusion of the family 
in both the research and the intervention itself was wel-
comed, with participants feeling that it was appropriate 
to focus upon the family. Young people and their families 
reported that they had been very happy to be involved in 
the trial and had understood what they were consenting 
to participate in. Whilst participant motivation to con-
sent to the trial was typically to access intervention, par-
ticipants understood and were accepting that they may 
randomly be assigned to the delayed treatment arm. As 
such, the trial procedures were found to be acceptable to 
the trial population.
Fig. 1 CONSORT diagram. CAP-child and adolescent psychiatry
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Table 1 Participant & family demographic and clinical characteristics at recruitment
Immediate arm, 
n = 14
Delayed arm, n = 13 Total, n = 27
Age in years: mean (sd) 16.2 (1.3) 16.1 (1.5) 16.1 (1.4)
Index of Multiple Deprivation: mean (sd) 23.4 (14.8) 23.2 (11.1) 23.3 (12.9)
CGAS rating: mean (sd)
 Current (last 2 weeks) 84 (7) 81.4 (5.2) 82.7 (6.3)
 Most severe past episode 25.1 (5) 22.4 (8.1) 23.8 (6.8)
 Highest in prior year 81 (7) 81.5 (5) 81.2 (7)
Gender: n (%)
 Female 13 (92.9) 10 (76.9) 23 (85.2)
Ethnicity: n (%)
 White British 13 (92.9) 12 (92.3) 25 (92.6)
 White other 0 (0) 1 (7.7) 1 (3.7)
 Mixed 1 (7.1) 0 (0) 1 (3.7)
Type of bipolar disorder: n (%)
 Bipolar I 8 (57.1) 7 (53.8) 15 (55.6)
 Bipolar II 6 (42.9) 5 (38.5) 11 (40.7)
 Bipolar NOS 0 (0) 1 (7.7) 1 (3.7)
Comorbid disorders
 GAD 0 (0) 2 (15.4) 2 (7.4)
 ASD 2 (14.3) 2 (15.4) 4 (14.8)
 ADHD 1 (7.1) 0 (0) 1 (3.7)
 ASD + ADHD 1 (7.1) 0 (0) 1 (3.7)
 Substance abuse or dependence disorder (past 3 months) 0 (0) 0 (0) 0 (0)
Mood episodes
 Age of diagnosis of BD in years mean (sd) 12.8 (1.6) 12.9 (1.3) 12.8 (1.4)
Hypomania
 Number of participants n (%) 8 (57.1) 8 (61.5) 16 (59.3)
 Number of episodes mean (sd) 3 (1.1) 2.9 (2) 3 (1)
 Lifetime duration in weeks mean (sd) 7.8 (4.4) 8.6 (4.5) 8.1 (4.3)
 Admissions to hospital 0 (0) 0 (0) 0 (0)
Mania
 Number of participants n (%) 8 (57.1) 7 (53.8) 15 (55.6)
 Number of episodes mean (sd) 2.9 (0.8) 2.7 (0.8) 2.8 (0.8)
 Lifetime duration in weeks mean (sd) 13.4 (5.2) 14 (5.3) 13.7 (5.1)
 Number of participants experiencing psychotic episodes n (%) 5 (35.7) 4 (30.1) 9 (33.3)
 Admissions to hospital n (%) 4 (30.1) 3 (23.1) 7 (25.9)
Depression
 Number of participants n (%) 14 (100) 13 (100) 27 (100)
 Number of episodes mean (sd) 4.2 (1.1) 4.2 (1.1) 4.2 (1.1)
 Lifetime duration in weeks mean (sd) 37.2 (16.9) 35.9 (16.2) 36.6 (16.5)
 Number of participants experiencing psychotic episodes n (%) 10 (71.4) 9 (69.2) 19 (70.4)
 Admissions to hospital n (%) 7 (50) 6 (46.2) 13 (48.1)
Medication treatments at trial entry
 Mood stabilizer 5 (35.7) 5 (38.5) 10 (37)
 Antipsychotic 8 (57.1) 10 (76.9) 18 (66.7)
 Other 1 (7.1) 0 (0) 1 (3.7)
 None 4 (28.6) 0 (0) 4 (14.8)
Family medical history (first degree relatives)
 Bipolar disorder 5 (35.7) 4 (30.8) 9 (33.3)
 Depression 4 (28.6) 10 (76.9) 14 (51.9)
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[Psychiatrist’s name] asked if we would do it and 
anything, absolutely anything that will give us some 
insight. Because there was nothing there. Nothing, 
absolutely nothing (Mother of 16-year-old son).
Participants were accepting of baseline and follow-up 
assessment. Indeed, all trial processes were considered to 
be appropriate and participants reported being willing to 
comply.
Experience of intervention
The majority of participants found the educational com-
ponents of the FFT-A UK to be helpful, reporting that the 
information was useful in promoting understanding and 
acceptance of the young person’s diagnosis. Both young 
people and their family members reported feeling reas-
sured by the information, and the knowledge that others 
share some of their symptoms and experiences.
I remember they showed us a video of all these people in 
America who had had bipolar, and I got to a point where 
I was like was I doing all of that for attention…but then 
I watched them and my God, I realised it must really be 
bipolar. That’s when I think I finally accepted it (female 
aged 17 years).
The communication and problem-solving sessions 
were also generally well received, with a number of the 
participants reporting that they had experienced benefit 
from them. The opportunity to sit down as a family and 
talk about challenges they experienced with one another 
was valued by participants.
I think they actually helped [us] to communicate 
better, because there were a lot of times when we 
wouldn’t say what we were actually feeling to each 
other (female age 17 years).
Impact of the intervention
Many of the participants reported that they felt that 
the intervention had a positive impact upon them. For 
some, the intervention had helped them to understand 
the young person’s diagnosis, and how it affected them, 
enabling them to better manage their symptoms.
I know who I am now, and how I work, and what I 
can do to help myself, instead of just letting things 
get really bad again (female age 15 years).
For others, the benefit they perceived from the inter-
vention related to the quality of the family relations. 
Improved relationships with siblings in particular were 
discussed by participants. An increased understanding 
the young person’s diagnosis was reported to positively 
affect relationships. The combination of factual infor-
mation and an opportunity for the family to talk openly 
resulted in increased understanding between family 
members. This was often discussed in relation to sib-
lings, for whom the young person’s behaviour was often 
viewed as ‘attention seeking’ or resulting in ‘unfair leni-
ence’ from the parents.
The FAB study helped…[Young person’s brother] used 
to say, “Well, yes, she just wants more attention. She’s 
this. She’s that.” When he actually realised, he has a 
great deal of empathy. He can tell when she is playing 
me as opposed to illness, and he’s better at that than I 
am (mother of 15 year old daughter).
We have sister days and everything now (sister of 
17 year old female).
Some families reported that they had experienced 
improved family functioning following their involve-
ment in the FAB intervention. Participants discussed 
strategies they had developed to manage interactional 
difficulties or strains within the family home. Improved 
communication was also highlighted.
It’s more like we’re a team (father of 16-year-old 
daughter).
A number of participants however reported that 
whilst they found the sessions informative, they were 
not helpful in affecting change. This tended to relate to 
Table 1 (continued)
Immediate arm, 
n = 14
Delayed arm, n = 13 Total, n = 27
 Anxiety 2 (14.3) 1 (7.7) 3 (11.1)
 ADHD 2 (14.3) 3 (23.1) 5 (18.5)
 ASD 2 (14.3) 2 (15.4) 4 (14.8)
 Physical illness 1 (7.1) 0 (0) 1 (3.7)
 Other 2 (14.3) 3 (23.1) 5 (18.5)
CGAS Children’s Global Assessment Scale, NOS not otherwise specified, GAD generalised anxiety disorder, ASD autism spectrum disorder, ADHD attention deficit 
hyperactivity disorder
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Table 2 Quantitative outcome measure summaries at each time point and by randomised arms
Outcome measure Baseline 6-month follow-up 12-month follow-up
n
mean (sd)
Immediate arm Delayed arm Immediate arm Delayed arm Immediate arm Delayed arm
WEBWBSa 14
43.6 (8.6)
13
40.2 (8.9)
11
44.6 (9.4)
11
40.8 (9.3)
10
45.5 (9.2)
11
43.0 (6.7)
FADb 14 13 11 10 9 10
Problem solving 2.0 (0.5) 2.3 (0.5) 1.8 (0.3) 2.1 (0.4) 1.9 (0.5) 2.2 (0.3)
Communication 2.2 (0.4) 2.4 (0.6) 2.0 (0.4) 2.3 (0.5) 2.0 (0.4) 2.2 (0.5)
Roles 2.5 (0.3) 2.5 (0.4) 2.3 (0.4) 2.6 (0.5) 2.4 (0.3) 2.5 (0.5)
Affective responsiveness 2.0 (0.6) 2.4 (0.8) 1.8 (0.5) 2.3 (0.7) 1.7 (0.5) 2.2 (0.6)
Affective involvement 2.3 (0.4) 2.3 (0.4) 2.1 (0.4) 2.3 (0.3) 2.2 (0.5) 2.3 (0.5)
Behaviour control 2.0 (0.3) 2.0 (0.6) 1.7 (0.3) 1.9 (0.5) 1.8 (0.3) 1.7 (0.5)
general functioning 2.1 (0.4) 2.2 (0.6) 1.8 (0.3) 2.4 (0.6) 1.7 (0.4) 2.2 (0.3)
CBQ-parentc 14 13 11 10 9 10
Appraisal of young person 13.0 (9.4) 13.2 (6.8) 7.0 (6.2) 13.8 (7.0) 5.8 (5.4) 10.5 (8.6)
Appraisal of dyad 4.6 (4.1) 4.6 (3.5) 1.5 (1.9) 5.7 (4.1) 2.6 (2.9) 6.1 (6.7)
CBQ-adolescentc 14 13 11 11 10 11
Appraisal of parent 10.6 (9.2) 7.0 (6.3) 5.3 (7.4) 5.6 (5.6) 5.3 (7.0) 8.0 (6.0)
Appraisal of dyad 5.2 (4.4) 3.7 (3.4) 2.5 (2.9) 4.5 (3.0) 3.0 (3.3) 3.6 (3.9)
EQ-5D-Y
n
Frequency
 Mobility 14 13 11 11 10 11
 No problems 13 11 10 9 9 8
 Some problems 1 2 1 2 1 3
 A lot of problems 0 0 0 0 0 0
 Self care 14 13 11 11 10 11
 No problems 13 11 10 10 9 9
 Some problems 1 2 1 1 1 2
 A lot of problems 0 0 0 0 0 0
 Performing usual activities 14 13 11 11 10 0
 No problems 11 4 9 3 5 5
 Some problems 2 9 2 5 5 4
 A lot of problems 1 0 0 2 0 2
 Pain or discomfort 14 13 11 11 10 11
 No problems 8 7 8 7 6 6
 Some problems 6 4 3 4 3 5
 A lot of problems 0 2 0 0 1 0
 Feeling worried, sad or unhappy 14 13 11 11 10 11
 No problems 8 4 8 4 5 2
 Some problems 4 7 3 3 4 8
 A lot of problems 2 2 0 4 1 0
EQ-5D-3L
n
Frequency
 Mobility 14 12 11 10 9 10
 No problems 14 12 11 10 8 10
 Some problems 0 0 0 0 1 0
 A lot of problems 0 0 0 0 0 0
 Self care 14 12 11 10 9 10
 No problems 14 12 11 10 9 10
 Some problems 0 0 0 0 0 0
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a difficulty in putting the lessons into practice outside 
of the sessions.
Communication skills, I thought it was brilliant. 
But every time I tried to do that, I got shot down 
in flames (Father of 16-year-old female).
Really informative but when you’ve got a kid 
that doesn’t communicate, again, it doesn’t work 
(mother of 16-year-old son).
For a significant minority however, the sessions 
were highlighted as not sufficient to tackle what they 
considered to be substantial or complex difficulties. 
For some of the participants there was a sense that 
one must be realistic about the potential impact of a 
talking therapy, and that only small benefits could be 
expected. Others reported that the sessions were too 
basic to meet their needs resulting in disappointment.
What any parent or partner of somebody with 
bipolar would want is a cure. There’s no cure. 
Therefore, anything is a little bit of a toothless 
tiger (mother of a 15-year-old daughter).
The problems with my friends couldn’t be solved. I 
failed some of my classes, they can never be solved. 
I lost my dad, they can never be solved. ( female 
aged 17 years).
Improvements to the intervention
The timing of the intervention was considered by many 
to be very important. After receiving a diagnosis, many 
young people and their families had often made sig-
nificant effort to learn about PBD before attending the 
sessions, feeling in need of immediate and detailed 
information. As such, participants reported that they 
often received the intervention ‘too late’.
There is not point doing the sessions once person’s 
already been through all the crap …but if FAB was 
there sooner, maybe none of that would have hap-
pened (female aged 17 years).
Participants were mostly very positive about the skills 
of the practitioners delivering the intervention. These 
families spoke highly of the knowledge and expertise of 
the therapists, considering their attributes to be funda-
mental to their positive experience of the intervention. 
For a minority, however, the perceived lack of therapist 
skill was a major issue.
But the problem with the communication around 
the family and the problem solving is that [practition-
er’s name] is a brilliant case worker for [young person’s 
name] but she was out of her depth managing the fam-
ily dynamic. So we had one session like that, which was 
fairly disastrous ( father of a 12 year old son).
Table 2 (continued)
Outcome measure Baseline 6-month follow-up 12-month follow-up
n
mean (sd)
Immediate arm Delayed arm Immediate arm Delayed arm Immediate arm Delayed arm
 A lot of problems 0 0 0 0 0 0
 Performing usual activities 14 12 11 10 9 10
 No problems 13 8 10 9 9 7
 Some problems 1 4 1 1 0 3
 A lot of problems 0 0 0 0 0 0
 Pain or discomfort 14 12 11 10 9 10
 No problems 10 9 9 8 6 6
 Some problems 4 3 1 2 2 4
 A lot of problems 0 0 1 0 1 0
 Feeling worried, sad or unhappy 14 13 11 11 10 11
 No problems 5 4 9 5 7 3
 Some problems 8 7 2 4 2 4
 A lot of problems 1 1 0 1 0 3
a WEBWBS: higher score indicates better well-being
b FAD: higher score indicates unhealthy functioning
c CBQ: higher score indicates more conflict
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Post-trial focus groups
As part of the trial, all families participating in the 
research were invited to a series of 3 workshops focussing 
on sharing of research findings with participants and the 
planning of a subsequent definitive RCT. The participants 
from 9 families who attended (on average n = 19 (young 
people and parents across the 3 workshops) felt that the 
research findings resonated with them. In planning a fol-
lowing trial participants made a number of recommen-
dations. They felt that ‘when’ this type of intervention is 
offered to families is crucial; if it is too early post diagno-
sis, the family is likely to still be in the process of accept-
ance and if too late the family might have accessed many 
aspects of the intervention elsewhere reducing the poten-
tial benefits of the intervention. The families agreed that 
the ideal time would be between 3 months and 18 months 
post diagnosis. They also emphasised the need for the 
therapist not to be the same person offering routine care 
for the young person as this had occurred for some par-
ticipants and was not well received. Both young people 
and their family members recommended that the FFT-A 
UK should be offered should be 15–25 years rather than 
just under 18  years. They highlighted that this was the 
time of greatest need in light of multiple transitions such 
as moving to adult mental health services, starting col-
lege/university and/or living independently.
Discussion
Despite the previously reported rates of infrequent diag-
nosis of PBD in the UK (Stringaris et  al. 2010; Sharma 
et  al. 2016) this trial has demonstrated that an efficacy 
trial is likely to be feasible and able to recruit success-
fully to target from UK community based child and ado-
lescent mental health services. Further the intervention 
and the research protocol were found to be acceptable to 
the families who consented to take part in this pilot trial. 
The trial successfully recruited 81% of the target sample 
although recruitment took longer than originally antici-
pated (i.e. 18 months instead of 12 months). In terms of 
retention only two families (7.4%) dropped out shortly 
after randomisation which is a lower attrition rate than 
reported in previous US studies (17.2% 34, 15.2% 35).
It is relevant to note that adults with BD often indicate 
that their primary concerns are about the adverse impact 
that the illness has had on their psychosocial function-
ing such as family and social relationships, education or 
financial independence. As a consequence, they rated 
their social support networks as a more important factor 
determining their quality of life than their mental health 
(Michalak et al. 2006). These findings suggest that func-
tional as well as symptomatic recovery (Colom and Vieta 
2004) should be targeted in treatments for BD. Consid-
eration of these wider impacts have been shown to be 
especially important for young people with PBD and 
their families (Gomes et  al. 2016; Freeman et  al. 2009; 
Lofthouse and Fristad 2004). In our trial questionnaire 
completion rates were also encouraging and similar to 
previously published studies, where 82.8% of the partici-
pants completed 1-year follow-up (Miklowitz et al. 2008) 
and 84.4% of the participants had at least one follow-up 
interview (Miklowitz et al. 2014). The high rates of ques-
tionnaires completion not only indicate families’ com-
mitment to and their acceptance of the research process 
but also an appropriate choice of quantitative measures 
which were selected after extensive Patient and Public 
Involvement and Engagement (PPIE). Preparatory focus 
groups with families attending the National Special-
ist Adolescent Mood disorders Service (SAMS) based 
in Northeast England, as part of the Public and Patient 
Involvement to help develop the objectives for this pro-
ject, identified that young people with PBD and their 
families wanted help with understanding what PBD 
means for them, how they might relate to each other in a 
better way and how they could seek help when the clini-
cal situation deteriorated. They highlighted that their top 
priority was the need to assess the impact of any new 
non-pharmacological intervention on family functioning 
rather than just focussing on symptomatic recovery of 
the young person with PBD.
Although the participants in this trial were simi-
lar in age (mean = 16.1, SD = 1.4) to those recruited 
for the Miklowitz et  al. (2008) FFT-A randomised trial 
(mean = 14.5, SD = 1.6; n = 58), the ratio of girls who took 
part in the UK FAB trial was higher (85.2% compared to 
56.9%). This high percentage of female participants was 
surprising since the male to female ratio in bipolar disor-
der is equal (Blehar et al. 1998). The higher percentage of 
girls referred to the trial team was out with the research 
team’s control. Interestingly the ratio of young men and 
women who were approached and eventually consented 
to take part in the trial were similar.
These research findings suggested that participants 
were very supportive of the research, believing it to be 
important and necessary to progress effective interven-
tions for young people with PBD and their families. Par-
ticipants also found trial processes to be acceptable. The 
intervention was largely well received, with many young 
people and their families reporting a benefit which they 
attributed to the FAB intervention. There were mixed 
views however on the usefulness of the various compo-
nents of the intervention, as well as the duration. These 
findings highlight the importance of individualised ther-
apy for the treatment of YP with PBD as recommended 
in NICE guidelines (NICE 2014). Although a person-
alised approach is recommended in the current FFT-A 
UK training manual and sessions, however, some further 
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modification such as the inclusion of core sessions and 
additional, optional sessions were recommended by the 
families. This might enable FAB therapists and the family 
to work together to identify the content and depth most 
relevant to the family, whilst also avoiding excessive bur-
den of time.
Next steps
In keeping with the findings of the post-trial focus groups, 
a definitive RCT assessing the clinical and cost- effective-
ness of FFT-EOY is being planned. Although such a trial 
will benefit from the experience of completing this fea-
sibility and acceptability study, it will target a somewhat 
older age range (15–25-year olds: older adolescents and 
young adults) who have been recently diagnosed with 
BD (between 3 and 18  months earlier). To date, Family 
Focussed Treatment (FFT) and FFT-A have been used 
across 8 randomized controlled trials with adults and 
adolescents with BD. Combined with medication, FFT 
has been associated with more rapid recovery from mood 
episodes, a lower rate of recurrences, and lower levels of 
symptom severity compared to briefer forms of psychoe-
ducation and medications over 1–2 years (Miklowitz and 
Chung 2016). Miklowitz et al. have developed an adapted 
version of the intervention targeting 13–25 years of age 
(FFT-EOY (2008)) which our group has already adapted 
to the UK cultural context. Therefore, we anticipate the 
future definitive trial having an impact on both young 
adults and older adolescents. Furthermore, targeting this 
age group will increase the number of individuals availa-
ble for the trial and assist in achieving adequate power to 
observe definitive effects. The future definitive trial will 
contribute to a UK evidence base evaluating not only the 
clinical effectiveness but also the cost-effectiveness of a 
manualised psychological intervention for BD in the con-
text of the UK National Health Service (NHS).
Strengths and limitations
This evaluation of an RCT assessing the feasibility and 
acceptability of FFT-A UK version in the management of 
PBD and further focus groups with participants suggest 
that recruitment to a definitive trial assessing effective-
ness and cost-effectiveness of a similar intervention in 
the age range 15–25 years would be possible. In our trial, 
although the initial recruitment was slower than antici-
pated (a common finding in intervention trials], once the 
trial became more widely known, the resulting momen-
tum allowed recruitment to 81.8% of target sample and 
retention of 92.6% of consented sample.
To our knowledge this is the first UK trial of FFT-A 
UK for young people with PBD which has included an 
embedded qualitative trial. Our research included young 
people, their parents as well as other key family members, 
therefore gathering a range of views. We purposively 
sampled male family members, often underrepresented 
in research involving parents which typically gathers the 
views of mothers. Despite our efforts, most of our sam-
ple was female, a trial limitation. Further, we were only 
able to interview young people and participants who 
consented to join the research trial investigating the fea-
sibility and acceptability of a psychoeducational interven-
tion. The trial did not include measures of mood severity 
as it was felt that this would not be relevant to the trial 
aims but a definitive trial will include these as outcome 
measures.
Conclusions
It was feasible to recruit participants to this feasibility 
and acceptability trial. Furthermore, retention rates were 
also satisfactory in this trial. The results highlighted that 
trial design and measures were acceptable to partici-
pants. A benefit in family relationships was reported by 
participants which they attributed to the intervention in 
qualitative interviews. Families made recommendations 
for future modifications. Focus groups recommended 
that the future definitive trial recruit participants in the 
age range 15–25 years (between 3- and 18-months post 
diagnosis) as it felt this was the age range with maximum 
need. Given the positive demonstrated benefits for both 
adults and adolescents with age-appropriate versions of 
FFT, we think this age range would be a suitable approach 
to definitively study clinical- and cost-effectiveness of the 
FFT-EOY.
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